Philip Morris International (PM) 8-KOther Events

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 30, 2024

Philip Morris International Inc.

(Exact name of registrant as specified in its charter)

Registrant’s telephone number, including area code: (203) 905-2410

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01. Other Events.

On November 1, 2024, Philip Morris International Inc. (“PMI”) issued $750,000,000 aggregate principal amount of its 4.375% Notes due 2027 (the “2027 Notes”), $750,000,000 aggregate principal amount of its 4.625% Notes due 2029 (the “2029 Notes”), $750,000,000 aggregate principal amount of its 4.750% Notes due 2031 (the “2031 Notes”) and $750,000,000 aggregate principal amount of its 4.900% Notes due 2034 (the “2034 Notes” and, together with the 2027 Notes, the 2029 Notes and the 2031 Notes, the “Notes”). The Notes were issued pursuant to an Indenture dated as of April 25, 2008, by and between PMI and HSBC Bank USA, National Association, as trustee.

In connection with the issuance of the Notes, on October 30, 2024, PMI entered into a Terms Agreement (the “Terms Agreement”) with BBVA Securities Inc., BofA Securities, Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, Wells Fargo Securities, LLC, Barclays Capital Inc., Citigroup Global Markets Inc., Mizuho Securities USA LLC and UBS Securities LLC, as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which PMI agreed to issue and sell the Notes to the Underwriters. The provisions of an Underwriting Agreement, dated as of April 25, 2008 (the “Underwriting Agreement”), are incorporated by reference in the Terms Agreement.

PMI has filed with the Securities and Exchange Commission a Prospectus dated February 10, 2023 and a Prospectus Supplement (the “Prospectus Supplement”) dated October 30, 2024 (Registration No. 333-269690) in connection with the public offering of the Notes.

PMI intends to add the net proceeds of the offering to its general funds, which may be used for general corporate purposes, to prepay a portion of or all borrowings outstanding under the 3-year tranche of its senior unsecured term loan facility, dated June 23, 2022 (the “Term Loan Facility”), to repay outstanding commercial paper, or to meet its working capital requirements.

The Notes are subject to certain customary covenants, including limitations on PMI’s ability, with significant exceptions, to incur debt secured by liens and engage in sale/leaseback transactions. PMI may redeem the Notes, in whole or in part, at the applicable redemption prices described in the Prospectus Supplement, plus accrued and unpaid interest thereon to, but excluding, the applicable redemption date. PMI may also redeem all, but not part, of the Notes of each series upon the occurrence of specified tax events as described in the Prospectus Supplement.

Interest on the 2027 Notes is payable from November 1, 2024 semiannually in arrears on May 1 and November 1 of each year, commencing May 1, 2025, to holders of record on the preceding April 15 or October 15, as the case may be. Interest on the 2029 Notes is payable from November 1, 2024 semiannually in arrears on May 1 and November 1 of each year, commencing May 1, 2025, to holders of record on the preceding April 15 or October 15, as the case may be. Interest on the 2031 Notes is payable from November 1, 2024 semiannually in arrears on May 1 and November 1 of each year, commencing May 1, 2025, to holders of record on the preceding April 15 or October 15, as the case may be. Interest on the 2034 Notes is payable from November 1, 2024 semiannually in arrears on May 1 and November 1 of each year, commencing May 1, 2025, to holders of record on the preceding April 15 or October 15, as the case may be.

The 2027 Notes will mature on November 1, 2027, the 2029 Notes will mature on November 1, 2029, the 2031 Notes will mature on November 1, 2031 and the 2034 Notes will mature on November 1, 2034.

The Notes will be PMI’s senior unsecured obligations and will rank equally in right of payment with all of its existing and future senior unsecured indebtedness.

For a complete description of the terms and conditions of the Underwriting Agreement, the Terms Agreement and the Notes, please refer to such agreements and the form of Notes, each of which is incorporated herein by reference and is an exhibit to this report as Exhibits 1.1, 1.2, 4.1, 4.2, 4.3 and 4.4, respectively.

Certain of the Underwriters and their respective affiliates have, from time to time, performed, and may in the future perform, various financial advisory, commercial and investment banking services for PMI, for which they received or will receive customary fees and expenses. Certain of the Underwriters and their respective affiliates are lenders under PMI’s credit facilities, including the 3-year tranche of its Term Loan Facility. Accordingly, such Underwriters or their affiliates that are also lenders under the 3-year tranche of PMI’s Term Loan Facility may receive a portion of the proceeds from this offering in connection with PMI’s repayment of borrowings under the 3-year tranche of the Term Loan Facility. PMI and some of its subsidiaries may enter into foreign exchange and other derivative arrangements with certain of the Underwriters or their respective affiliates. In addition, certain of the Underwriters or their respective affiliates act as dealers in connection with PMI’s commercial paper programs.

Item 9.01. Financial Statements and Exhibits.

SIGNATUREs

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DATE: November 1, 2024